FDA Inspection 1080726 — Welgo LLC
The FDA completed an inspection of Welgo LLC on March 25, 2019 in Temple Hills, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Temple Hills, MD (United States)